Neuro-mechanical motility and transit vectors.
Layer 1 is a physical constraint on everything downstream. If the wall cannot clear the lumen, ecology and bioenergetics are being asked to work against a transport problem. This page resolves that layer at the level of ion channels, motor proteins, junction geometry, and chromatin state — the mechanistic detail behind the canonical framework and the interactive systems map.
Educational systems-biology analysis. Mechanisms described here are a mixture of established physiology and inference; each module separates what holds under intact host capacity from what is proposed to happen when it fails, and the claim ledger below records the evidence tier and the strongest alternative explanation for each target. Nothing here is diagnostic or a treatment protocol.
The intestinal bioreactor — laminar flow and the stagnant film
Treated as a flexible piping network, small-intestinal flow sits at a very low Reynolds number (Re = ρvd/μ, Re ≪ 10), so the regime is strictly laminar. Radial mixing depends on coordinated segmenting contractions rather than turbulence.
- — Segmenting contractions supply the radial mixing that laminar flow cannot generate on its own.
- — Nutrients, enzymes, and microbial metabolites are advected away from the epithelial wall.
- — Local metabolite concentration at the brush border stays below mucosal clearance capacity.
- — As the velocity vector approaches zero, advective transport collapses.
- — The system becomes diffusion-limited: a stagnant film layer forms along the enterocyte brush border.
- — Microbially derived organic acids may pool locally, exceeding mucosal clearance — a transport problem before it is an ecological one.
The SIP syncytium — pacemaker, integrator, and brake
The intestinal smooth-muscle wall is not isolated tissue but an electrically and structurally coupled collective: smooth muscle cells (SMCs), interstitial cells of Cajal (ICCs), and PDGFRα⁺ cells [1.6].
[ PACEMAKER NODE ] [ EXCITATORY INTEGRATOR ] [ INHIBITORY CONTROLLER ]
ICC network Smooth muscle (SMCs) PDGFRa+ cells
Generates slow wave Executes contraction Dampens excitability
via ANO1 Cl- efflux via Cav1.2 Ca2+ influx via SK3 K+ efflux
| | |
+--------------------------+----------------------------+
|
[ GAP JUNCTION COUPLING (Cx43) ]- — ICC networks generate the inward depolarising pacing current through ANO1 chloride channels.
- — Inhibitory motor neurons release purines onto P2Y1 receptors on PDGFRα⁺ cells; the resulting Ca²⁺ surge opens SK3 channels and hyperpolarises the syncytium toward −70 mV.
- — The balance between ANO1 depolarisation and SK3 hyperpolarisation sets whether muscle responds to pacing.
- — Accumulating D-lactate and H₂S may activate KATP channels on SMCs and PDGFRα⁺ cells, mimicking continuous inhibitory neural firing.
- — The hyperpolarising brake can lock 'on', leaving muscle refractory to arriving pacing waves.
- — This is a candidate explanation for functional electromechanical paralysis that prokinetics do not override — the muscle is electrically unavailable, not under-stimulated.
ANO1 pacing, Cx43 uncoupling, and ICC-DMP loss
Slow-wave generation depends on rhythmic intracellular Ca²⁺ oscillations in the ICC-MP syncytium coupled to muscle through Connexin 43 gap junctions [1.2, 1.3].
- — IP₃-receptor-gated Ca²⁺ release activates ANO1; chloride efflux depolarises the ICC from about −65 mV toward −20 mV.
- — The wave propagates through Cx43 gap junctions, opening myocyte Cav1.2 channels and driving MLCK phosphorylation and contraction.
- — ICC-DMP populations mediate neurotransmission between enteric motor neurons and muscle.
- — Hypoxia and mitochondrial ATP depletion may reduce ANO1 transcription and membrane stability; pacing amplitude falls below the Cav1.2 activation threshold and degrades into sub-threshold noise.
- — IL-1β and TNF-α activate JNK, which phosphorylates Cx43 at serine residues — internalisation closes the gap junctions and uncouples pacemaker from muscle.
- — ICC-DMP atrophy removes the cellular bridge prokinetics rely on, a candidate reason 5-HT4 agonists underperform in these phenotypes.
The nano-junctional pacing gate (IP₃R ↔ ANO1)
Pacing fidelity depends on physical distance: the ER IP₃ receptors and plasma-membrane ANO1 channels must sit within roughly 30 nm of each other [1.10].
[ INTRACELLULAR SINK ] [ MEMBRANE CHANNEL ]
ER IP3R Ca2+ "sparks" ANO1 Ca2+-activated Cl- channel
| |
+----------------+-----------------------+
|
[ MATRIX: DESMIN & VINCULIN hold <30 nm proximity ]
|
[ ACIDOSIS -> gap widens -> diffusion dissipates the spark ]- — Ca²⁺ sparks released into the tiny nano-junctional volume drive local concentration past ~10 µM almost instantly.
- — That surge satisfies ANO1 binding requirements, opening the pore and triggering slow-wave depolarisation.
- — Desmin and vinculin tether the ER membrane to the plasma membrane, holding the geometry.
- — Microbially derived D-lactate driving intracellular acidosis may alter the charge state of desmin and vinculin anchors.
- — The ER drifts, widening the junction from ~30 nm to over 100 nm.
- — By three-dimensional diffusion, the spark dissipates into the cytoplasm before reaching the membrane; local concentration never reaches the ANO1 threshold and the slow wave flatlines.
Piezo2 mechanogating and the S-nitrosylation lock
Piezo2 is a homotrimeric mechanosensitive channel with curved propeller blades set in the bilayer; membrane tension flattens the blades and opens a non-selective pore [1.9].
- — Wall strain gates Piezo2, admitting Ca²⁺ and Na⁺ into nitrergic (nNOS⁺) inhibitory motor neurons.
- — Local nitric oxide relaxes smooth muscle ahead of a moving bolus — descending relaxation as designed.
- — Hyper-compliant connective tissue (hEDS spectrum) or a stagnant bolus alters baseline bilayer tension, so gating becomes uncoordinated.
- — Excess NO may S-nitrosylate cysteine residues on MLCK and Cav1.2 in adjacent myocytes.
- — S-nitrosylated Cav1.2 resists Ca²⁺ influx even when a pacing wave arrives; S-nitrosylated MLCK loses affinity for Ca²⁺/calmodulin. The cell is biochemically uncoupled from its own electrical signal and held relaxed.
Muscularis macrophage–ENS crosstalk and neuro-immune shearing
Resident muscularis macrophages form a lattice around enteric neuronal somas, axons, and ICC networks, exchanging trophic signals with them [1.7].
Luminal barrier breach -> LPS / peptidoglycan into muscularis externa
|
TLR4 / MyD88 -> NF-kB : macrophage phenotype shift
|
BMP2 output halts; IL-1b / TNF-a rise
|
MMP-3 / MMP-9 cleave Ret (GDNF) and c-Kit (SCF) receptors
|
Neuronal and ICC apoptosis -> pacing amplitude falls- — Enteric neurons secrete M-CSF and BMP11, holding macrophages in an anti-inflammatory, tissue-protective phenotype.
- — Macrophages return BMP2, which acts on neuronal BMPR1A/BMPR2 to tune cholinergic firing frequency and orderly propulsion.
- — Barrier degradation lets LPS and peptidoglycan reach the muscularis externa, activating macrophage TLR4 via MyD88/NF-κB.
- — BMP2 production halts; local IL-1β and TNF-α rise.
- — IL-1β upregulates MMP-3 and MMP-9, which may cleave the extracellular domains of Ret and c-Kit — removing GDNF and stem-cell-factor survival signalling from neurons and pacemakers alike. The structural loss is a candidate correlate of persistently low pacing amplitude on high-resolution manometry.
Enteric glia — GDNF withdrawal, Cx43 hemichannels, and P2X7 excitotoxicity
Enteric glial cells set baseline ENS excitability by controlling extracellular ATP through Connexin 43 hemichannels, and sustain neurons through GDNF [1.4, 1.11].
- — Homeostatic glia are high-GDNF / low-GFAP: GDNF acts on neuronal RET receptors through PI3K/Akt and MAPK/ERK survival signalling.
- — Controlled ATP release through Cx43 hemichannels tunes neuronal firing thresholds; CD39/NTPDase1 clears the excess.
- — Pooled organic acids and endotoxin may flip glia to a reactive profile: GDNF down, S100B and iNOS up.
- — NO plus superoxide yields peroxynitrite, nitrating tyrosine residues on neuronal structural proteins — a candidate mechanism for nitrergic and cholinergic loss (muscularis plexitis).
- — H₂S may alter Cx43 disulfide bonds and lock hemichannels open; the resulting ATP flood overwhelms CD39 and drives P2X7 large-pore activation, Ca²⁺/Na⁺ overload, and myenteric neuronal apoptosis.
Neuropod synaptic machinery and vagal uncoupling
Enteroendocrine cells are polarised neuro-epithelial cells whose basal process forms a true synapse — under 30 nm — with vagal afferent terminals [1.5, 1.8].
Luminal ligands bind EEC GPCRs
|
P/Q-type Ca2+ influx -> SNARE (SNAP-25 / syntaxin-1 / VAMP-2) fusion
|
Glutamate / CCK exocytosed across the <30 nm cleft to vagal afferents
|
[ FAILURE ] mast cell chymase / tryptase cleave N-cadherin & NCAM
|
Neuropod retracts -> vagus functionally blind to the lumen- — The basal extension carries presynaptic machinery: synapsin-1, synaptophysin, and the SNARE complex.
- — Luminal ligands binding EEC GPCRs trigger P/Q-type Ca²⁺ influx and vesicular release of glutamate and CCK directly onto the vagal terminal — sensing in milliseconds, not hormone-diffusion minutes.
- — A markedly skewed secondary-to-primary bile-acid ratio raises hydrophobic DCA and LCA, which may activate mucosal mast cells through non-IgE pathways.
- — Chymase and tryptase released into the lamina propria can cleave the adhesion scaffolding (N-cadherin, NCAM) tethering neuropod to nerve.
- — Proteolytic shearing retracts the neuropod process: the sensory link is broken before any efferent vagal response can be evaluated — a candidate account of gut–brain uncoupling that is structural rather than 'low vagal tone'.
The integrin–talin–vinculin mechanical clutch
Cells transduce external force through focal adhesions; talin acts as a linear spring between integrin and the actin cytoskeleton [1.12].
- — Integrins bind ECM proteins (fibronectin, tenascin-X — structurally altered in hEDS).
- — At roughly 2–5 pN of tension the talin rod unfolds, exposing cryptic binding sites.
- — Vinculin docks onto those sites and anchors the complex to actin, letting the cell absorb peristaltic force without tearing.
- — In post-infectious phenotypes with anti-vinculin autoantibodies, antibody binding to the vinculin D1 domain may sterically prevent docking onto unfolded talin.
- — The clutch slips: mechanical force dissipates into the plasma membrane instead of the cytoskeleton.
- — Micro-tears, Ca²⁺ influx, and calpain activation are candidate contributors to localised ICC–smooth-muscle network degradation.
Axonal transport bioenergetics — kinesin stall and spheroid formation
Neuronal terminals depend on ATP-driven kinesin-1 walking 8-nm steps along microtubules at roughly 1 µm/s, one ATP per step [1.13].
- — Forward transport delivers acetylcholine machinery and neurotrophins such as GDNF to the synapse.
- — Local ATP stays well above the motor's Km (~60 µM), so velocity is substrate-independent.
- — Localised Complex IV inhibition by H₂S, or organic-acid load, may drop the axonal ATP/ADP ratio.
- — Below Km, Michaelis–Menten kinetics take kinesin velocity toward zero.
- — Cargo continues arriving: vesicles pool, the axon swells into spheroids, and the terminal is functionally de-innervated even though the neuron is alive.
Epigenetic silencing of the c-Kit⁺ pacemaker stem niche
ICC networks are renewed from c-Kit⁺ mesenchymal precursors in the muscularis externa; Kit and Ano1 transcription requires accessible chromatin held open by NAD⁺-dependent SIRT1 [1.14, 1.15].
NAD+ pool depleted (chronic CD38 activation)
|
SIRT1 deacetylase activity falls
|
H3K9ac / H3K14ac hyper-acetylation at the Kit promoter
|
MBD proteins + DNMT1 / DNMT3b recruited -> heterochromatin
|
RNA Pol II excluded -> c-Kit expression lost -> niche exhaustion- — SIRT1 keeps promoter chromatin in a dynamically open state so RNA Pol II can bind.
- — Precursors differentiate into mature ICCs, replacing pacemakers lost to ordinary turnover.
- — Chronic NAD⁺ depletion — the same CD38-driven tax described in the bioenergetic layer — deprives SIRT1 of substrate.
- — Unchecked acetyltransferase activity and subsequent methyl-CpG/DNMT recruitment may condense the Kit promoter into heterochromatin.
- — If precursors cannot express c-Kit, pacemaker replacement stops. This is the model's most consequential and least certain claim: it proposes a point at which Layer 1 loss becomes difficult to reverse.
What would test each claim — and what else could explain it
| Mechanistic target | Metric / proxy | Evidence tier | Alternative explanations |
|---|---|---|---|
| ANO1 channel de-entrainment | High-density electrogastroenterography mapping slow-wave power spectral density. | High-fidelity research inference | Primary hypercalcaemia altering smooth-muscle resting membrane potential. |
| Purinergic SK3 hyperpolarisation | Faecal H₂S quantification with reduced resting baseline tone on high-resolution anorectal manometry. | Cell bioenergetics model | Primary genetic channelopathies affecting voltage-gated potassium channels (e.g. KCNQ). |
| MMP-mediated myenteric atrophy | Serum or urinary MMP-3 / MMP-9 elevation with absent response to high-dose 5-HT4 agonists. | High-fidelity research inference | Paraneoplastic neuropathy; amyloid deposition within the muscularis coat. |
| Neuropod synaptic disruption | Disproportionate plasma CCK / PYY response to standardised oral macronutrient challenge. | Systemic inference | Congenital neuroendocrine cell hypoplasia; superior mesenteric artery ischaemia. |
| Piezo2-mediated nitrergic lock | Tissue S-nitrosylation metrics with paradoxical delayed colonic transit on wireless capsule manometry. | Cell bioenergetics model | Autoimmune neuropathy targeting voltage-gated calcium channels (Lambert-Eaton phenotypes). |
| Nano-junction splitting | Loss of slow-wave phase-locking across multi-channel electrogastroenterography. | High-fidelity research inference | Genetic variants in intracellular calcium-handling proteins (e.g. ryanodine receptor). |
| P2X7-mediated excitotoxicity | Extracellular ATP or soluble CD39 markers in targeted tissue biopsy. | Emerging metric | Enteric vascular ischaemia; mechanical mesenteric compromise. |
| Vinculin steric slip | Optical-tweezer dissociation constants for anti-vinculin antibodies on unfolded talin, ex vivo. | High-fidelity research inference | Primary variants in the vinculin head-to-tail auto-inhibition loop. |
| Kinesin motor stalling | Localised phosphorylated neurofilament heavy chain accumulation on myenteric biopsy mapping. | High-fidelity research inference | Kinesin superfamily motor-domain mutations (e.g. KIF5A). |
| Epigenetic Kit silencing | ChIP-seq mapping H3K9ac density at the Kit promoter in mesenchymal lineages. | Cell bioenergetics model | Primary loss-of-function mutation at the c-Kit locus (piebaldism variants). |
See the full claim ledger and framework audit for how evidence tiers are assigned.
Where the leverage would sit if the model is right
These are mechanistic targets a licensed clinician might weigh, not recommendations, dosing, or treatment. BiomeLogic does not diagnose, prescribe, or treat.
Releasing the purinergic brake
Where a sulfide pattern is documented, reducing H₂S production is a candidate route to lifting KATP/SK3-driven hyperpolarisation, shifting resting membrane potential back into a range where remaining pacemaker waves can be answered. This is reasoning about a target, not a protocol.
Reversing the macrophage TLR4 switch
Reducing the translocating antigen load, and dampening NF-κB tone in muscularis macrophages, may permit BMP2 synthesis to resume and lower local MMP-3/MMP-9 — the condition under which surviving ENS architecture could repair receptor connections.
Re-anchoring the pacemaker nano-junction
If intracellular acidosis widens the IP₃R–ANO1 gap, then correcting the acid load and supporting cytoskeletal anchoring is the mechanistically coherent target rather than adding prokinetic drive to a muscle that cannot receive it.
Protecting the neural plexus
Limiting glial hemichannel ATP release and mucosal mast-cell proteolysis addresses the two candidate routes to irreversible loss — P2X7 excitotoxicity and neuropod synaptic shearing. Preservation is the goal; regeneration is not assumed.
Primary literature anchors
- [1.1] Transport physics of laminar intestinal flow and diffusion-limited stagnant film layers.
- [1.2] Sanders KM, Ward SM, Koh SD. Interstitial cells: regulators of smooth muscle function. Physiological Reviews.
- [1.3] Hwang SJ et al. ANO1 (TMEM16A) is essential for slow-wave activity in gastrointestinal muscles. Journal of Physiology.
- [1.4] Gulbransen BD, Sharkey KA. Novel roles for enteric glia in intestinal neurotransmission and tissue homeostasis. Nat Rev Gastroenterol Hepatol 2012;9(11):625-632.
- [1.5] Bohórquez DV et al. Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest.
- [1.6] Sanders KM, Koh SD, Ward SM. Interstitial cells of Cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol 2006;68:307-343.
- [1.7] Muller PA, Koscsó B, Rajani GM, et al. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell 2014;158(2):300-313.
- [1.8] Kaelberer MM, Buchanan KL, Klein ME, et al. A gut-brain neural circuit for nutrient sensory transduction. Science 2018;361(6408):eaat5236.
- [1.9] Coste B, Mathur J, Schmidt M, et al. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science 2010;330(6000):55-60.
- [1.10] Drumm BT, Remmele M, Sanders KM. Nano-junctions and structural microenvironments in interstitial cells of Cajal pacemaking. Journal of Physiology 2019;597(14):3651-3668.
- [1.11] Gulbransen BD, Sharkey KA. Purinergic neuron-to-glia signalling and Cx43 hemichannels in the enteric nervous system.
- [1.12] del Rio A et al. Stretching single talin rod molecules activates vinculin binding. Science.
- [1.13] Svoboda K, Block SM. Force and velocity measured for single kinesin molecules. Cell.
- [1.14] Lorincz A et al. Progenitors of interstitial cells of Cajal in the postnatal murine stomach. Gastroenterology.
- [1.15] Imai S, Guarente L. NAD⁺ and sirtuins in ageing and disease. Trends in Cell Biology.
Gate 1 is only a fit screen. No labs or files are required.
Educational systems-biology consulting. Not diagnosis or treatment. Designed to work alongside your licensed medical team.